参考文献/References:
[1]Arslan M,Degirmencioglu S.Risk factors for postembolization syndrome after transcatheter arterial chemoembolization[J].Curr Med Imaging Rev.2019,15:380-385.
[2]罗朝霞,夏辉,龚昭,等.肝动脉化疗栓塞联合阿帕替尼治疗中晚期肝癌有效性和安全性Meta分析[J].临床外科杂志,2022,30:1129-1132.
[3]于翔,成思航,曹磊,等.术前全身免疫炎症指数与DEB-TACE治疗肝癌患者预后相关性分析[J].介入放射学杂志,2021,30:461-465.
[4]周禄科,杨洁,刘林,等.92例老年肝癌患者TACE后肝功能代偿不全的危险因素分析[J].临床消化病杂志,2022,34:189-193.
[5]高斯媛,杨晓冬,王丽萍,等.肝细胞癌TACE术后出现栓塞后综合征对患者临床死亡率的相关性分析[J].现代消化及介入诊疗,2020,25:230-233.
[6]李娟,李晓,周纪妹.肝癌经导管动脉化疗栓塞术后发生栓塞综合征的影响因素[J].癌症进展,2023,21:499-501.
[7]He J,Yin X,Wang T,et al.Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization[J].J Cancer Res Ther,2021,17:777-783.
[8]孔令玲,钟丽霞,杨洋,等.经导管肝动脉化疗栓塞术后栓塞综合征的研究现状及护理进展[J].中华现代护理杂志,2021,27:976-980.
[9]何佳枫,戚龙菊,余静,等.居家有氧运动对肝癌肝动脉化疗栓塞术患者症状群的干预研究[J].中国康复医学杂志,2022,37:470-475.
[10]周春梅.循证护理干预原发性肝癌肝动脉化疗栓塞术后患者并发症的效果[J].慢性病学杂志,2021,22:792-794.
相似文献/References:
[1]李大伟,周振堰,周长友,等.ALT/AST及影像学特征预测肝癌经动脉化疗栓塞患者的预后 [J].介入放射学杂志,2024,33(08):849.
LI Dawei,ZHOU Zhenyan,ZHOU Changyou,et al. Application of serum AST/ALT ratio and imaging features in predicting the prognosis of patients with hepatocellular carcinoma after receiving transarterial chemoembolization[J].journal interventional radiology,2024,33(11):849.
[2]耿鹏,付强,卢钟琦,等.肝癌热消融的研究热点和趋势可视化分析[J].介入放射学杂志,2024,33(08):870.
GENG Peng,FU Qiang,LU Zhongqi,et al.Visualization analysis of the hot spots and trends in thermal ablation studies of hepatocellular carcinoma [J].journal interventional radiology,2024,33(11):870.